Healthy
Healthy volunteer studies play a critical role in advancing medical research by establishing the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational therapies. CenExel partners with sponsors to deliver high-quality Phase I and early clinical studies through experienced research teams, specialized facilities, and dedicated volunteer recruitment programs.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Early-Phase Clinical Research
Healthy volunteer research provides the foundation for clinical development programs. CenExel's specialized research sites support first-in-human, bioavailability, bioequivalence, pharmacokinetic, and safety studies across a wide range of therapeutic areas.
Our experienced investigators and research teams deliver precise data collection, participant safety monitoring, and regulatory compliance throughout every study phase.
By combining operational excellence with robust volunteer recruitment capabilities, we help sponsors accelerate development timelines while maintaining the highest standards of quality and participant care.
Conditions Covered
Healthy Volunteer Studies We Support
Our health and wellness expertise goes beyond participant enrollment — we deliver clinical insight, operational excellence, and dependable outcomes that advance healthier lives.
First-in-Human (FIH) Studies
Phase I Clinical Trials
Pharmacokinetic (PK) Studies
Pharmacodynamic (PD) Studies
Bioavailability Studies
Bioequivalence Studies
Drug-Drug Interaction Studies
Food Effect Studies
Single Ascending Dose (SAD) Studies
Vaccine Studies
Our Approach
Why Sponsors Choose CenExel for Healthy Volunteer Research
Our healthy volunteer and wellness research expertise extends beyond enrollment — providing scientific guidance, efficient execution, and trusted results that support medical innovation.
01
Rapid Study Start-Up
Experienced teams and streamlined processes enable efficient study activation and execution.
02
Dedicated Healthy Volunteer Recruitment
Access to diverse and well-characterized participant populations through established recruitment networks.
03
Early-Phase Research Expertise
Extensive experience conducting first-in-human, PK/PD, and bioavailability studies.
04
Safety-First Operations
Comprehensive medical oversight and participant monitoring throughout every study.
Phase Coverage
Supported Trial Phases
We support healthy volunteer studies across multiple stages of development, including:
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.